Article

Massie Labs brings digital eye imaging to adult patients

New Orleans-Massie Laboratories Inc. introduces the ADIS-9000, a device that brings the company's RetCam technology for early detection of pediatric eye diseases to the adult market.

ADIS-9000 is a new tool for panoramic imaging of the adult anterior segment. Clinicians can visualize and document pathologies that occur in the front chamber of the eye, including views of the iridocorneal angle. This provides for detection and monitoring of primary open-angle glaucoma, which represents about 80% of known glaucoma patients around the world.

ADIS-9000 offers high-resolution, hand-held versatility to a variety of ophthalmic specialties in the private practice setting. In addition, the ADIS-9000, which records and replays digital video of examination segments for dynamic documentation, offers both high-resolution digital still or full-resolution digital video imaging options.

Using a technique similar to an ultrasound exam, the learning curve for the ADIS-9000 user is dramatically short, measured in minutes rather than months, as with previously available methods. Live images, displayed on the system's high-resolution LCD monitor, offer instant feedback for image orientation and focus, making the recording of still images or recording of a dynamic procedure achievable at any skill level.

"Existing photography technology of this very discreet area of the eye takes many years to master and requires a great deal of skill and practice," said Bert Massie, PhD, founder, chairman, and chief executive officer of Massie Labs. "With its digital imaging capability and its ease-of-use, the ADIS-9000 provides superior images and offers convenience to practitioners and maximum comfort for their patients."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.